New eye drop aims to tame glaucoma pressure in major trial
NCT ID NCT07335211
First seen Jan 14, 2026 · Last updated Apr 29, 2026 · Updated 15 times
Summary
This phase 3 trial tests a new eye drop called HUC3-637 in 206 adults with primary open-angle glaucoma or high eye pressure. The goal is to see if it lowers eye pressure better than an existing active control. Participants will use the drops for a period and have their eye pressure measured regularly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kangbuk Samsung Hospital
RECRUITINGSeoul, South Korea
Conditions
Explore the condition pages connected to this study.